Heart Team risk assessment with angiography‐derived fractional flow reserve determining the optimal revascularization strategy in patients with multivessel disease: Trial design and rationale for the DECISION QFR randomized trial

Kotaro Miyata(St. Luke's International Hospital), Keita Masuda(St. Luke's International Hospital), Yoshiharu Higuchi(Hyogo Prefectural Nishinomiya Hospital), Masahiro Hoshino(Gifu Heart Center), Koki Ouchi(St. Luke's International Hospital), Takayuki Okamura(Yamaguchi University), Hideaki Nonaka(Mitsui Memorial Hospital), Nobuyuki Komiyama(St. Luke's International Hospital), Takayoshi Kanie(St. Luke's International Hospital), Manabu Yamasaki(St. Luke's International Hospital), Johan H. C. Reiber(Erasmus University Rotterdam), Yoshimitsu Takaoka(St. Luke's International Hospital), Yosuke Miyazaki(Yamaguchi University), Shoichi Kuramitsu(Kokura Memorial Hospital), Kunihiko Yoshino(St. Luke's International Hospital), Norihiro Kogame(Amsterdam UMC Location University of Amsterdam), Yosuke Nishihata(St. Luke's International Hospital), Yohei Sotomi(Kyoto University), Hiroki Emori(Wakayama Medical University), Taku Asano(Amsterdam UMC Location University of Amsterdam), Yumi Shiina, Toru Tanigaki(Gifu Heart Center), Hitoshi Matsuo, Rihito Tamaki(St. Luke's International Hospital), Akira Saito(St. Luke's International Hospital), Takahiro Suzuki(St. Luke's International Hospital), Kohei Abe(St. Luke's International Hospital), Hiroyuki Kodama(Osaka University of Pharmaceutical Sciences), Kengo Tanabe, Tomoaki Kobayashi(Osaka Police Hospital), Naoki Wakabayashi(St. Luke's International Hospital), Yuki Katagiri(University of Amsterdam), Motoki Yasunaga(Osaka Police Hospital), Tsunekazu Kakuta(Onze Lieve Vrouwziekenhuis Hospital), Hiroyasu Misumi
Clinical Cardiology
March 31, 2022
10.1002/clc.23821
Cited by 6

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels
|Circulation|1995|844
In Vivo Diagnosis of Plaque Erosion and Calcified Nodule in Patients With Acute Coronary Syndrome by Intravascular Optical Coherence Tomography
|Journal of the American College of Cardiology|2013|840
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|781